Related Experiment Video
Updated: Dec 28, 2025

05:05
Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
12.6K
Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Luca Agnifili1, Lorenza Brescia1, Barbara Scatena1
1Department of Medicine and Aging Science, Ophthalmology Clinic, G. D'Annunzio University of Chieti-Pescara, Chieti.
Journal of Glaucoma
|February 22, 2020
Summary
Medically controlled glaucoma patients exhibit dry eye disease-like conditions, with reduced tear meniscus height and area observed via AS-OCT. These structural changes may indicate ocular surface disease related to glaucoma therapy.
Area of Science:
- Ophthalmology
- Ocular Surface Disease
Background:
- Glaucoma treatment can lead to ocular surface disease.
- Anterior segment-optical coherence tomography (AS-OCT) is a valuable tool for imaging ocular structures.
Purpose of the Study:
- To investigate tear meniscus characteristics in medically controlled glaucoma patients (MCGP) using AS-OCT.
- To compare tear meniscus parameters between MCGP, evaporative dry eye (EDE) patients, and healthy controls.
Main Methods:
- AS-OCT was used to measure tear meniscus height (TMH) and area (TMA) in 56 MCGP, 24 EDE patients, and 30 controls.
- MCGP were categorized by glaucoma medication: beta-blockers, prostaglandin analogs, or multiple drugs.
- Ocular Surface Disease Index (OSDI), tear film break-up time, corneal staining, and Schirmer Test I were also performed.
Main Results:
- Lower tear meniscus area (L-TMA) and height (L-TMH) were found in all MCGP groups and EDE patients compared to controls.
- L-TMA and L-TMH were significantly lower in patients using multiple glaucoma medications (group 3) and EDE patients compared to those using single-drug therapies.
- OSDI scores were higher in EDE patients and group 3, and negatively correlated with L-TMA and L-TMH.
Conclusions:
- AS-OCT provides noninvasive tear meniscus imaging in MCGP, revealing a dry eye disease-like condition.
- Reduced TMH and TMA can serve as structural indicators of ocular surface disease associated with glaucoma therapy.
Related Concept Videos
Open Angle Glaucoma: Treatment
900
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
900
Angle Closure Glaucoma: Treatment
1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K

